lincomycin has been researched along with Pneumonia, Viral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pagano, JS; Sarubbi, FA | 1 |
2 other study(ies) available for lincomycin and Pneumonia, Viral
| Article | Year |
|---|---|
WITHDRAWN: The comparison of the effectiveness of lincocin® and azitro® in the treatment of covid-19-associated pneumonia: A prospective study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Betacoronavirus; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; Female; Humans; Lincomycin; Male; Middle Aged; Pandemics; Pneumonia, Viral; Prospective Studies; Risk Factors; SARS-CoV-2 | 2020 |
Pneumonia.
Topics: Ampicillin; Anti-Bacterial Agents; Bronchopneumonia; Cephalexin; Cephalothin; Erythromycin; Gentamicins; Haemophilus Infections; Humans; Klebsiella Infections; Lincomycin; Methicillin; Mycoplasma Infections; Penicillin G; Penicillins; Pneumonia; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Pneumonia, Viral | 1972 |